| DERIVATIVES | 3 Months Ended | 
|---|---|
| Mar. 31, 2024 | |
| Derivatives [Abstract] | |
| Derivatives | NOTE 5 – DERIVATIVES The Company enters into derivative financial instruments to manage exposures receipt or payment of future known and uncertain cash amounts, the value of derivative financial instruments are used to manage differences in expected cash receipts and its known or expected cash payments principally Cash Flow Hedges of Interest Rate Risk  Interest rate swaps with notional amounts totaling $ 30 debt. 2.50 % and receive a variable interest rate based on  three-month CME Term For derivatives designated and that qualify as cash flow hedges of interest rate accumulated other comprehensive income (“AOCI”) and subsequently which the hedged transaction affects earnings. Amounts reported will be reclassified to interest expense as interest payments are made on the The following table reflects the cash flow hedges included in the consolidated Statement of Financial  Notional  Fair  Weighted Average  (Dollars in Thousands)  Condition Location  Amount  Value  March 31, 2024  Interest rate swaps related to subordinated debt  Other Assets  $  30,000 $  5,755 6.3 December 31, 2023  Interest rate swaps related to subordinated debt  Other Assets  $  30,000 $  5,317 6.5 The following table presents the net gains (losses) recorded in AOCI and the flow derivative instruments (interest rate swaps related to subordinated Amount of (Loss)  Amount of Gain  Gain Recognized  (Loss) Reclassified  (Dollars in Thousands)  Category  in AOCI  from AOCI to Income  Three months ended March 31, 2024  Interest expense  $  326 $  375 Three months ended March 31, 2023  Interest expense  (598) 309 The Company estimates there will be approximately $ 1.3 months.  The Company had a collateral liability of $ 5.9 5.5 |